← Open Payments lookup

VICENTE LIM: Open Payments

NPI 1275529356 · ROSELLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,174 in 144 payments from 10 companies in 2025. Trend: 2023 $2,076 · 2024 $2,157 · 2025 $2,174

Food & beverage: $2,174
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.26$391
Neurocrine BioSciences, Inc.23$352
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$341
ABBVIE INC.15$218
Alkermes, Inc.11$199
Luye Pharma (USA) Ltd.14$191
E.R. Squibb & Sons, L.L.C.16$181
Janssen Pharmaceuticals, Inc10$160
Lundbeck LLC5$86
Otsuka America Pharmaceutical, Inc.3$55

Products named: INGREZZA, CAPLYTA, UZEDY, VRAYLAR, ERZOFRI EXTENDED-RELEASE, COBENFY, INVEGA SUSTENNA, ARISTADA.

Industry payments across NJ — which companies pay providers there.